EUVIMEDEUVIMED entdecken
Crossref

Tumor Microenvironment Modulating CaCO 3 ‐Based Colloidosomal Microreactors Can Generally Reinforce Cancer Immunotherapy

Ziliang Dong, Yan Liu, Chunjie Wang, Yu Hao, Qin Fan, Zhijuan Yang, Quguang Li, Liangzhu Feng, Zhuang Liu iD

Advanced Materials · 2024-03 · 36 (9)

DOI: 10.1002/adma.202308254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 14.12.2023. Verfasst von Ziliang Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano and Soft Materials (FUNSOM), Soochow Universit…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Research Programs from Ministry of Science and Technology (MOST) of China, Startup Foundation of the Shandong First Medical University, Suzhou Key Laboratory of Nanotechnology and Biomedicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor hypoxia and acidity, two general features of solid tumors, are known to have negative effect on cancer immunotherapy by directly causing dysfunction of effector immune cells and promoting suppressive immune cells inside tumors. Herein, a multifunctional colloidosomal microreactor is constructed by encapsulating catalase within calcium carbonate (CaCO 3 ) nanoparticle‐assembled colloidosomes (abbreviated as CaP CSs) via the classic double emulsion method. The yielded CCaP CSs exhibit well‐retained proton‐scavenging and hydrogen peroxide decomposition performances and can thus neutralize tumor acidity, attenuate tumor hypoxia, and suppress lactate production upon intratumoral administration. Consequently, CCaP CSs treatment can activate potent antitumor immunity and thus significantly enhance the therapeutic potency of coloaded anti‐programmed death‐1 (anti‐PD‐1) antibodies in both murine subcutaneous CT26 and orthotopic 4T1 tumor xenografts. In addition, such CCaP CSs treatment also markedly reinforces the therapeutic potency of epidermal growth factor receptor expressing chimeric antigen receptor T (EGFR‐CAR‐T) cells toward a human triple‐negative breast cancer xenograft by promoting their tumor infiltration and effector cytokine secretion. Therefore, this study highlights that chemical modulation of tumor acidity and hypoxia can collectively reverse tumor immunosuppression and thus significantly potentiate both immune checkpoint blockade and CAR‐T cell immunotherapies toward solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsHumansAnimalsMiceImmunotherapyImmunosuppression TherapyLactic Acid

Stichwörter der Autor:innen

CAR-T cell therapyCaCO3 based colloidosomal microreactorsICB immunotherapyacidity neutralizationhypoxia attenuation

Substanzen

Lactic Acid

Autor:innen und Institutionen

  • Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Institute of Functional Nano and Soft Materials (FUNSOM), Soochow University, 199 Ren'ai Road, Suzhou, Jiangsu, 215123, P. R. China.
  • Science and Technology Innovation Center, Shandong First Medical University, Jinan, Shandong, 250000, P. R. China.
  • Jiangsu Key Laboratory for Molecular and Medical Biotechnology, Cancer Institute, Department of Biochemistry, College of Life Science, Nanjing Normal University, Nanjing, 210023, P. R. China.

ORCID-Profile: Zhuang Liu

Förderung

  • National Research Programs from Ministry of Science and Technology (MOST) of China
  • Startup Foundation of the Shandong First Medical University
  • Suzhou Key Laboratory of Nanotechnology and Biomedicine
  • Collaborative Innovation Center of Suzhou Nano Science and Technology
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Dong, Z., Liu, Y., Wang, C., Hao, Y., Fan, Q., Yang, Z., Li, Q., Feng, L., & Liu, Z. (2024). Tumor Microenvironment Modulating CaCO 3 ‐Based Colloidosomal Microreactors Can Generally Reinforce Cancer Immunotherapy. Advanced Materials, 36(9). https://doi.org/10.1002/adma.202308254

Vancouver

Dong Z, Liu Y, Wang C, Hao Y, Fan Q, Yang Z, et al. Tumor Microenvironment Modulating CaCO 3 ‐Based Colloidosomal Microreactors Can Generally Reinforce Cancer Immunotherapy. Advanced Materials. 2024;36(9). doi:10.1002/adma.202308254

BibTeX
@article{Dong2024,
  author = {Dong, Ziliang and Liu, Yan and Wang, Chunjie and Hao, Yu and Fan, Qin and Yang, Zhijuan and Li, Quguang and Feng, Liangzhu and Liu, Zhuang},
  title = {Tumor Microenvironment Modulating CaCO 3 ‐Based Colloidosomal Microreactors Can Generally Reinforce Cancer Immunotherapy},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {9},
  doi = {10.1002/adma.202308254}
}
Kostenlos starten →